EE61 Economic Burden of Gastroesophageal Reflux Disease, Barrett's Esophagus, and Esophageal Neoplasia in the United States

Autor: Sharma, P, Falk, GW, Bhor, M, Ozbay, AB, Latremouille-Viau, D, Guérin, A, Shi, S, Elvekrog, MM, Limburg, P

Publikováno v: In Value in Health July 2022 25(7) Supplement:S347-S347

PHS132 - Exploring The Real World Setting Of Chronic Kidney Disease Patient And Physician Behaviors Across Countries: Disease-Specific Programmes

Autor: Piercy, J., Ozbay, AB, Taylor-Stokes, G., Marx, S.E.

Publikováno v: In Value in Health May 2013 16(3):A209-A209

Trends in Colorectal Cancer Screening from the National Health Interview Survey: Analysis of the Impact of Different Modalities on Overall Screening Rates.

Autor: Ebner DW; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota., Finney Rutten LJ; Division of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Miller-Wilson LA; Exact Sciences Corporation, Madison, Wisconsin., Markwat N; Markwat Consulting, Sweden., Vahdat V; Exact Sciences Corporation, Madison, Wisconsin., Ozbay AB; Exact Sciences Corporation, Madison, Wisconsin., Limburg PJ; Exact Sciences Corporation, Madison, Wisconsin.

Publikováno v: Cancer prevention research (Philadelphia, Pa.) [Cancer Prev Res (Phila)] 2024 Jun 04; Vol. 17 (6), pp. 275-280.

Impact of Eliminating Cost-Sharing by Medicare Beneficiaries for Follow-Up Colonoscopy After a Positive Stool-based Colorectal Cancer Screening Test.

Autor: Fendrick AM; Department of Internal Medicine and Department of Health Management and Policy, Division of General Medicine, University of Michigan, Ann Arbor, Michigan., Lieberman D; Division of Gastroenterology and Hepatology, School of Medicine, Oregon Health and Science University, Portland, Oregon., Chen JV; Exact Sciences Corporation, Madison, Wisconsin., Vahdat V; Exact Sciences Corporation, Madison, Wisconsin., Ozbay AB; Exact Sciences Corporation, Madison, Wisconsin., Limburg PJ; Exact Sciences Corporation, Madison, Wisconsin.

Publikováno v: Cancer research communications [Cancer Res Commun] 2023 Oct 17; Vol. 3 (10), pp. 2113-2117.

Effectiveness of HCC surveillance programs using multitarget blood test: A modeling study.

Autor: Chhatwal J; Massachusetts General Hospital Institute for Technology Assessment, Harvard Medical School, Department of Radiology, Boston, Massachusetts, USA.; Dana Farber/Harvard Cancer Center, Boston, Massachusetts, USA., Samur S; Value Analytics Labs, Boston, Massachusetts, USA., Yang JD; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, California, USA., Roberts LR; Mayo Clinic, Division of Gastroenterology and Hepatology, Rochester, Minnesota, USA., Nguyen MH; Division of Gastroenterology and Hepatology, Department of Epidemiology and Population Health, Stanford University Medical Center, Palo Alto, California, USA., Ozbay AB; Exact Sciences Corporation, Madison Wisconsin, USA., Ayer T; Georgia Institute of Technology, Department of Industrial and Systems Engineering, Atlanta, Georgia, USA.; Emory Medical School, Department of Internal Medicine, Atlanta, Georgia, USA., Parikh ND; University of Michigan Medical School, Ann Arbor, Michigan, USA., Singal AG; University of Texas Southwestern Medical Center, Department of Internal Medicine, Dallas, Texas, USA.

Publikováno v: Hepatology communications [Hepatol Commun] 2023 May 18; Vol. 7 (6). Date of Electronic Publication: 2023 May 18 (Print Publication: 2023).